A detailed history of D. E. Shaw & Co., Inc. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 8,760 shares of ANIP stock, worth $514,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,760
Holding current value
$514,912
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$58.53 - $68.82 $512,722 - $602,863
8,760 New
8,760 $557,000
Q2 2022

Aug 15, 2022

SELL
$23.09 - $33.46 $338,337 - $490,289
-14,653 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$26.91 - $47.15 $572,806 - $1 Million
-21,286 Reduced 59.23%
14,653 $412,000
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $607,439 - $1.05 Million
18,424 Added 105.19%
35,939 $1.66 Million
Q3 2021

Nov 15, 2021

SELL
$26.48 - $35.99 $195,925 - $266,290
-7,399 Reduced 29.7%
17,515 $575,000
Q2 2021

Aug 16, 2021

SELL
$31.86 - $38.6 $440,687 - $533,915
-13,832 Reduced 35.7%
24,914 $873,000
Q1 2021

May 17, 2021

BUY
$28.4 - $36.14 $348,922 - $444,016
12,286 Added 46.43%
38,746 $1.4 Million
Q4 2020

Feb 16, 2021

BUY
$23.69 - $31.47 $626,837 - $832,696
26,460 New
26,460 $768,000
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $494,533 - $827,802
-16,523 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$30.35 - $67.14 $621,628 - $1.38 Million
-20,482 Reduced 55.35%
16,523 $673,000
Q4 2019

Feb 14, 2020

BUY
$55.65 - $79.83 $153,371 - $220,011
2,756 Added 8.05%
37,005 $2.28 Million
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $1.22 Million - $1.61 Million
18,892 Added 123.02%
34,249 $2.5 Million
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $559,441 - $678,561
8,255 Added 116.23%
15,357 $1.26 Million
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $59,945 - $92,266
1,308 Added 22.58%
7,102 $501,000
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $28,819 - $39,508
700 Added 13.74%
5,794 $261,000
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $269,727 - $363,405
5,094 New
5,094 $288,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.02B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.